Figure 6From: Hsp70 - a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neckNK cell activatory markers on peripheral blood lymphocytes (PBL) of SCCHN patients before and at indicated time-points after therapy. EDTA blood samples from selected patients (n = 7) were collected at indicated time points before therapy (1), after tumor resection before start of radiation therapy (2), in the 1st year of follow-up (3), and in the 2nd year of follow-up (4). The time points of surgery and radiation are indicated with S and R in the upper part of each graph. NK cells were stained by using the lysis-wash method and analyzed by flow cytometry. A-F. CD56-positive and CD3-negative NK cells were gated and analyzed. Mean fluorescence intensity (mfi) of CD56, CD94, NKG2D, NKp30, NKp44, NKp46 were determined. Time-curves are shown for individual patients. G. Mean fluorescence intensity values of all markers of all patients with error bars and standard deviations (n = 7). Samples were taken before therapy (1), after tumor resection before start of radiation therapy (2), in the 1st year of follow-up (3), and in the 2nd year of follow-up (4) * p<0.05.Back to article page